• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于杜普伊特伦挛缩临床评估的手印验证

Validation of a Handprint for Clinical Evaluation of Dupuytren's Contracture.

作者信息

Ajiki Takashi, Murayama Akira, Hayashi Yukinori, Takeshita Katsushi

机构信息

Department of Orthopedic Surgery, Jichi Medical University, Tochigi, Japan.

Department of Orthopedic Surgery, Ishibashi General Hospital, Tochigi, Japan.

出版信息

J Hand Microsurg. 2021 Aug 25;15(3):181-187. doi: 10.1055/s-0041-1735347. eCollection 2023 Jun.

DOI:10.1055/s-0041-1735347
PMID:37388561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10306974/
Abstract

We have developed a handprint-based method for visualizing and quantifying the palmar contact of patients with Dupuytren's contracture. The purpose of this study was to examine whether the generated handprint was useful for assessing the severity of flexion contracture of the fingers and for evaluating the therapeutic effects of collagenase clostridium histolyticum (CCH) injection for Dupuytren's contracture.  The handprint was created by applying medical-grade ethanol-containing hand sanitizer over the entire palmar surface of the affected hand and then pressing it on thermal paper for word processors. The reliability of the handprint was evaluated through test-retest of 10 healthy volunteers at an interval of 10 days, and the validity of the handprint was assessed using a flexion contracture model in which the little finger was fixed in an Alfence splint. In addition, we obtained handprints of the affected hand in 33 patients with unilateral Dupuytren's contracture both before CCH injection and at the final observation after injection to investigate the contact area of the hand (CAH) and the length of the hand (LH). The relationships between CAH, LH, total extension deficit angle (TEDA), and patient-reported outcome measures (Japanese Society for Surgery of the Hand Version of the Quick Disability of Arm, Shoulder, and Hand Questionnaire [Quick DASH-JSSH] and Hand20) were examined.  The test-retest correlation coefficient was 0.9187 (  < 0.001) for CAH and 0.9052 (  < 0.001) for LH, indicating high reliability of the handprint. The ratios of CAH and LH decreased gradually as the contracture angle of the splinted finger increased. The handprint revealed a marked improvement of palmar contact after CCH injection for Dupuytren's contracture. Furthermore, the ratios of CAH and LH were strongly correlated with TEDA, Quick DASH-JSSH, and Hand20 before treatment.  Our handprint-based assessment method was extremely useful for clinical evaluation of CCH treatment for Dupuytren's contracture.  Therapeutic.

摘要

我们开发了一种基于手印的方法,用于可视化和量化掌腱膜挛缩症患者的手掌接触情况。本研究的目的是检验所生成的手印是否有助于评估手指屈曲挛缩的严重程度,以及评估溶组织梭状芽孢杆菌胶原酶(CCH)注射治疗掌腱膜挛缩症的疗效。

手印是通过将含医用级乙醇的洗手液涂抹在患手的整个手掌表面,然后按压在用于文字处理的热敏纸上制成的。通过对10名健康志愿者进行间隔10天的重测来评估手印的可靠性,并使用将小指固定在Alfence夹板中的屈曲挛缩模型来评估手印的有效性。此外,我们获取了33例单侧掌腱膜挛缩症患者在CCH注射前和注射后最终观察时患手的手印,以研究手部接触面积(CAH)和手长(LH)。研究了CAH、LH、总伸展缺损角度(TEDA)与患者报告的结局指标(日本手部外科学会版手臂、肩部和手部快速残疾问卷[Quick DASH-JSSH]和Hand20)之间的关系。

CAH的重测相关系数为0.9187(<0.001),LH的重测相关系数为0.9052(<0.001),表明手印具有较高的可靠性。随着夹板固定手指的挛缩角度增加,CAH和LH的比例逐渐降低。手印显示CCH注射治疗掌腱膜挛缩症后手掌接触有明显改善。此外,治疗前CAH和LH的比例与TEDA、Quick DASH-JSSH和Hand20密切相关。

我们基于手印的评估方法对于掌腱膜挛缩症CCH治疗的临床评估极为有用。

治疗性。

相似文献

1
Validation of a Handprint for Clinical Evaluation of Dupuytren's Contracture.用于杜普伊特伦挛缩临床评估的手印验证
J Hand Microsurg. 2021 Aug 25;15(3):181-187. doi: 10.1055/s-0041-1735347. eCollection 2023 Jun.
2
Dupuytren's Contracture Recurrence and Treatment Following Collagenase Clostridium Histolyticum Injection: A Longitudinal Assessment in a Veteran Population.《胶原酶注射治疗后Dupuytren 挛缩复发及处理:退伍军人人群的纵向评估》
Mil Med. 2023 Aug 29;188(9-10):e2975-e2981. doi: 10.1093/milmed/usad075.
3
4
Percutaneous Needle Fasciotomy versus Collagenase Injection for Dupuytren's Contracture: A Systematic Review of Comparative Studies.经皮针状筋膜切开术与胶原酶注射治疗掌腱膜挛缩症的比较研究的系统评价
J Hand Microsurg. 2021 Jul;13(3):150-156. doi: 10.1055/s-0040-1721876. Epub 2020 Dec 31.
5
Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.胶原酶注射与经皮针刀松解治疗掌腱膜挛缩症的疗效比较:3 年随访的客观和主观比较。
Plast Reconstr Surg. 2020 Jun;145(6):1464-1474. doi: 10.1097/PRS.0000000000006828.
6
Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.溶组织梭状芽孢杆菌胶原酶治疗掌腱膜挛缩症时的皮肤撕裂伤
Orthop Nurs. 2018 Mar/Apr;37(2):144-153. doi: 10.1097/NOR.0000000000000435.
7
Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial.# 标题:迪普伊特伦氏干预手术与胶原酶(DISC)试验:一项实用、双臂平行组、非劣效性随机对照试验的研究方案。 # 译文解析: - 标题中的“Dupuytren's”和“DISC”是医学专有名词,分别是迪普伊特伦氏病和胶原酶的缩写,可直接保留英文; - “interventions surgery”和“collagenase”是“迪普伊特伦氏干预手术”和“胶原酶”的英文表达,在标题中为常见医学缩写,可直接保留英文; - “versus”是英文词汇,可直接保留; - “protocol”是“方案”的意思,可保留英文; - “pragmatic”是“实用的”的意思,“parallel-group”是“平行组”的意思,“non-inferiority”是“非劣效性”的意思,“randomised controlled trial”是“随机对照试验”的意思,均为医学专业词汇,可保留英文。
Trials. 2021 Sep 30;22(1):671. doi: 10.1186/s13063-021-05595-w.
8
Factors predicting the 1-year outcome of collagenase treatment for Dupuytren's disease.预测Dupuytren病胶原酶治疗1年预后的因素。
Arch Orthop Trauma Surg. 2019 Apr;139(4):583-588. doi: 10.1007/s00402-019-03120-y. Epub 2019 Jan 23.
9
Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren's contracture in non-Caucasian Japanese patients (CORD-J Study): the first clinical trial in a non-Caucasian population.组织型胶原酶注射治疗非白种日本患者掌腱膜挛缩症的疗效与安全性(CORD-J研究):非白种人群中的首个临床试验
J Hand Surg Eur Vol. 2017 Jan;42(1):30-38. doi: 10.1177/1753193416653249. Epub 2016 Sep 28.
10
Can collagenase effectiveness in Dupuytren's contracture be improved by using ultrasound-guided Injection? A comparative study.超声引导注射能否提高胶原酶治疗掌腱膜挛缩的效果?一项对比研究。
J Plast Surg Hand Surg. 2022 Feb;56(1):23-29. doi: 10.1080/2000656X.2021.1901723. Epub 2021 Apr 11.

本文引用的文献

1
Patient Satisfaction With Collagenase.患者对胶原酶的满意度。
J Hand Surg Am. 2016 Jun;41(6):689-97. doi: 10.1016/j.jhsa.2016.03.003. Epub 2016 Apr 28.
2
Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren's disease.用于Dupuytren病时,手臂、肩部和手部患者报告结局量表(DASH)及快速DASH的效度。
J Hand Surg Eur Vol. 2016 Jul;41(6):589-99. doi: 10.1177/1753193415601350. Epub 2015 Aug 25.
3
Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren's contracture: validity evidence using Rasch modeling.用于评估杜普伊特伦挛缩症患者上肢、肩部和手部功能障碍的DASH量表的心理测量学评价:基于拉施模型的效度证据
BMC Musculoskelet Disord. 2014 Oct 30;15:361. doi: 10.1186/1471-2474-15-361.
4
Reliability of the Hand20 questionnaire: comparison with the 36-Item Short-Form Health Survey.手部20项问卷的信度:与36项简短健康调查问卷的比较
Hand Surg. 2014;19(1):1-6. doi: 10.1142/S0218810414500014.
5
URAM scale for functional assessment in Dupuytren's disease: a comparative study of its properties.用于掌腱膜挛缩症功能评估的URAM量表:其特性的比较研究
Joint Bone Spine. 2014 Oct;81(5):441-4. doi: 10.1016/j.jbspin.2014.01.007. Epub 2014 Feb 22.
6
The Southampton Dupuytren's Scoring Scheme.南安普敦掌腱膜挛缩评分系统。
J Plast Surg Hand Surg. 2014 Feb;48(1):28-33. doi: 10.3109/2000656X.2013.794349. Epub 2013 May 13.
7
Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.评估治疗杜普伊特伦挛缩病的最佳功能结局测量指标:系统评价及对未来实践的建议。
BMC Musculoskelet Disord. 2013 Apr 10;14:131. doi: 10.1186/1471-2474-14-131.
8
Unité Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren's disease-specific disability.手部疾病风湿单元(URAM)量表:一种评估特定于杜普伊特伦病的残疾的工具的开发和验证。
Arthritis Care Res (Hoboken). 2011 Oct;63(10):1448-55. doi: 10.1002/acr.20564.
9
The treatment of Dupuytren disease.掌腱膜挛缩症的治疗
J Hand Surg Am. 2011 May;36(5):936-42. doi: 10.1016/j.jhsa.2011.03.002.
10
Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.注射用溶组织梭状芽孢杆菌胶原酶:一种治疗杜普伊特伦挛缩症的新型非手术疗法。
J Hand Surg Am. 2010 Dec;35(12):2027-38.e1. doi: 10.1016/j.jhsa.2010.08.007.